CONFLICT OF INTEREST STATEMENT

EV has received grants and served as consultant, advisor or CME speaker for the following entities (unrelated to the present work): AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis and Takeda. IP has received CME-related honoraria, or consulting fees from Janssen-Cilag, Lundbeck, Lundbeck/Otsuka, CASEN Recordati and Angelini, with no financial or other relationship relevant to the subject of this article. AGP has received CME-related honoraria or consulting fees from Angelini, Janssen-Cilag, Casen Recordati, Rovi, LCN and Lundbeck, and reports no financial or other relationship relevant to the subject of this article. PB has received CME-related honoraria from Lundbeck and reports no financial or other relationship relevant to the subject of this article. MV has received research grants from Eli Lilly & Company and has served as a speaker for Abbot, Bristol-Myers Squibb, GlaxoSmithKline, Janssen-Cilag and Lundbeck. The rest of the authors report no biomedical financial interests or potential conflicts of interest related to the present article.

中文翻译：

---

大麻戒断和躁狂发作：双相情感障碍未知触发因素的三例

利益冲突声明

EV 已获得资助并担任以下实体的顾问、顾问或 CME 演讲者（与目前的工作无关）：AB-Biotics、雅培、艾尔建、Angelini、大日本住友制药、费雷尔、Gedeon Richter、杨森、灵北、大冢、 Sage、赛诺菲-安万特和武田。 IP 已从 Janssen-Cilag、Lundbeck、Lundbeck/Otsuka、CASEN Recordati 和 Angelini 收到与 CME 相关的酬金或咨询费，与本文主题没有任何财务或其他关系。 AGP 已从 Angelini、Janssen-Cilag、Casen Recordati、Rovi、LCN 和 Lundbeck 收到与 CME 相关的酬金或咨询费，并且报告没有与本文主题相关的财务或其他关系。 PB 已从灵北收到与 CME 相关的酬金，并且报告没有与本文主题相关的财务或其他关系。 MV 获得了礼来公司的研究资助，并曾担任 Abbot、百时美施贵宝、葛兰素史克、Janssen-Cilag 和 Lundbeck 的演讲者。其他作者报告没有与本文相关的生物医学经济利益或潜在利益冲突。